Pages that link to "Q80035224"
Jump to navigation
Jump to search
The following pages link to A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function (Q80035224):
Displaying 50 items.
- Mechanisms of dopamine transporter regulation in normal and disease states (Q24598750) (← links)
- R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse (Q24621917) (← links)
- The binding sites for cocaine and dopamine in the dopamine transporter overlap (Q24650126) (← links)
- Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition (Q24656589) (← links)
- Monoamine transporters: insights from molecular dynamics simulations (Q26777242) (← links)
- Insights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDAT (Q26781554) (← links)
- How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters (Q26866308) (← links)
- Spontaneous inward opening of the dopamine transporter is triggered by PIP2-regulated dynamics of the N-terminus (Q27300323) (← links)
- Neurotransmitter and psychostimulant recognition by the dopamine transporter (Q27316816) (← links)
- Modeling and dynamics of the inward-facing state of a Na /Cl- dependent neurotransmitter transporter homologue (Q27334606) (← links)
- A competitive inhibitor traps LeuT in an open-to-out conformation (Q27653127) (← links)
- Insights into transport mechanism from LeuT engineered to transport tryptophan (Q27674534) (← links)
- The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors (Q28477546) (← links)
- Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations (Q28533835) (← links)
- A conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporter (Q30368030) (← links)
- Generation of a 3D model for human GABA transporter hGAT-1 using molecular modeling and investigation of the binding of GABA. (Q30377894) (← links)
- Assessing the ability of sequence-based methods to provide functional insight within membrane integral proteins: a case study analyzing the neurotransmitter/Na symporter family (Q30481053) (← links)
- Substrate binding and formation of an occluded state in the leucine transporter (Q30481294) (← links)
- Time-resolved mechanism of extracellular gate opening and substrate binding in a glutamate transporter (Q30484136) (← links)
- Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood (Q30574381) (← links)
- Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. (Q30581669) (← links)
- A mechanism for intracellular release of Na by neurotransmitter/sodium symporters (Q30623808) (← links)
- Substrate-dependent proton antiport in neurotransmitter:sodium symporters (Q33600236) (← links)
- Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter. (Q33707171) (← links)
- Conformational dynamics of ligand-dependent alternating access in LeuT. (Q33729757) (← links)
- Not just an oil slick: how the energetics of protein-membrane interactions impacts the function and organization of transmembrane proteins. (Q33736493) (← links)
- Molecular modeling and ligand docking for solute carrier (SLC) transporters (Q33751096) (← links)
- Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation (Q33758304) (← links)
- The N terminus of monoamine transporters is a lever required for the action of amphetamines (Q33796294) (← links)
- Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine (Q33799683) (← links)
- The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter (Q33813126) (← links)
- Structural analysis of the extracellular entrance to the serotonin transporter permeation pathway (Q33832622) (← links)
- Comparison of human solute carriers (Q33836276) (← links)
- Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore. (Q33990707) (← links)
- A short update on the structure of drug binding sites on neurotransmitter transporters. (Q34108966) (← links)
- Conformational flexibility of transmembrane helix VII of the human serotonin transporter impacts ion dependence and transport. (Q34126464) (← links)
- Single-molecule dynamics of gating in a neurotransmitter transporter homologue (Q34130830) (← links)
- The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter (Q34137102) (← links)
- Reconstructing a chloride-binding site in a bacterial neurotransmitter transporter homologue (Q34152288) (← links)
- Cytoplasmic permeation pathway of neurotransmitter transporters (Q34202128) (← links)
- Structural dynamics of the monoamine transporter homolog LeuT from accelerated conformational sampling and channel analysis (Q34254774) (← links)
- GATMD: -Aminobutyric Acid Transporter Mutagenesis Database (Q34383067) (← links)
- Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site (Q34396818) (← links)
- High selectivity of the γ-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach (Q34397703) (← links)
- Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation (Q34568367) (← links)
- Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model (Q34597890) (← links)
- SLC6 transporters: structure, function, regulation, disease association and therapeutics (Q34649517) (← links)
- Computational modeling of the N-terminus of the human dopamine transporter and its interaction with PIP2 -containing membranes. (Q34668331) (← links)
- Homology modeling of human γ-butyric acid transporters and the binding of pro-drugs 5-aminolevulinic acid and methyl aminolevulinic acid used in photodynamic therapy (Q34769682) (← links)
- What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands? (Q34785448) (← links)